BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16959517)

  • 1. [Treatment response evaluation by functional imaging].
    Fournier LS; Cuénod CA; Clément O; Frija G
    Cancer Radiother; 2006 Nov; 10(6-7):484-7. PubMed ID: 16959517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Imaging of response to treatment in oncology].
    Fournier LS; Cuénod CA; Clément O; Siauve N; Frija G
    J Radiol; 2007 Jun; 88(6):829-43. PubMed ID: 17652977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging techniques to evaluate the response to treatment in oncology: current standards and perspectives.
    Marcus CD; Ladam-Marcus V; Cucu C; Bouché O; Lucas L; Hoeffel C
    Crit Rev Oncol Hematol; 2009 Dec; 72(3):217-38. PubMed ID: 18760935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Targeted treatments: which imaging?].
    Lassau N; Chebil M; Benatsou B; Chami L; Roche A
    Bull Cancer; 2008 Oct; 95(10):989-93. PubMed ID: 19004731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Functional imaging and radiotherapy].
    Lallemand F; Lakosi F; Hustinx R; Withofs N; Meunier P; Tshibanda L; Jodogne S; Coucke P; Martinive P
    Rev Med Liege; 2014; 69 Suppl 1():20-8. PubMed ID: 24822301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An introduction to functional and molecular imaging with MRI.
    Gallagher FA
    Clin Radiol; 2010 Jul; 65(7):557-66. PubMed ID: 20541655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular imaging in oncology: the diagnostic imaging "revolution".
    Larson SM
    Clin Cancer Res; 2000 Jun; 6(6):2125. PubMed ID: 10873059
    [No Abstract]   [Full Text] [Related]  

  • 9. Functional magnetic resonance imaging for defining the biological target volume.
    Kauczor HU; Zechmann C; Stieltjes B; Weber MA
    Cancer Imaging; 2006 Jun; 6(1):51-5. PubMed ID: 16766269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Utility of MRI contrast agents for diagnosis and treatment follow-up in cancer].
    Siauve N; Clément O
    Bull Cancer; 2007 Feb; 94(2):139-46. PubMed ID: 17337383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring changes in human tumour vasculature in response to therapy using functional imaging techniques.
    Anderson H; Price P; Blomley M; Leach MO; Workman P;
    Br J Cancer; 2001 Oct; 85(8):1085-93. PubMed ID: 11710817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional renal imaging: new trends in radiology and nuclear medicine.
    Durand E; Chaumet-Riffaud P; Grenier N
    Semin Nucl Med; 2011 Jan; 41(1):61-72. PubMed ID: 21111860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiological evaluation of the therapeutic response of malignant diseases: status quo, innovative developments and requirements for radiology.
    Höink AJ; Heindel W; Buerke B
    Rofo; 2014 Oct; 186(10):927-36. PubMed ID: 25122173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging prostate cancer.
    Jung AJ; Westphalen AC
    Radiol Clin North Am; 2012 Nov; 50(6):1043-59. PubMed ID: 23122037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of new imaging techniques to predict tumour response to therapy.
    Harry VN; Semple SI; Parkin DE; Gilbert FJ
    Lancet Oncol; 2010 Jan; 11(1):92-102. PubMed ID: 20129132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in magnetic resonance imaging of brain tumours.
    Lemort M; Canizares-Perez AC; Van der Stappen A; Kampouridis S
    Curr Opin Oncol; 2007 Nov; 19(6):616-22. PubMed ID: 17906462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRI and CT assessment.
    Cuenod CA; Fournier L; Balvay D; Guinebretière JM
    Abdom Imaging; 2006; 31(2):188-93. PubMed ID: 16447089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotyping of tumor biology in patients by multimodality multiparametric imaging: relationship of microcirculation, alphavbeta3 expression, and glucose metabolism.
    Metz S; Ganter C; Lorenzen S; van Marwick S; Herrmann K; Lordick F; Nekolla SG; Rummeny EJ; Wester HJ; Brix G; Schwaiger M; Beer AJ
    J Nucl Med; 2010 Nov; 51(11):1691-8. PubMed ID: 20956471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast-enhanced magnetic resonance imaging: applications in oncology.
    Teo QQ; Thng CH; Koh TS; Ng QS
    Clin Oncol (R Coll Radiol); 2014 Oct; 26(10):e9-20. PubMed ID: 24931594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cancer treatment response evaluation based on imaging modalities, such as computed tomography, magnetic resonance imaging and FDG-PET].
    Endo M; Aramaki T; Moriguchi M; Sawada A; Asakura K; Bekku E
    Gan To Kagaku Ryoho; 2013 Mar; 40(3):294-8. PubMed ID: 23507590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.